[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Page 5882]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01800]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)-RFA-IP-23-002, Understanding Adult Immunization 
Quality Improvement Approaches Among Adult HCP and Health Departments; 
and RFA-IP-23-003, Programmatic Interventions To Increase Uptake of 
Influenza and COVID-19 Vaccination Among Students Attending 
Institutions of Higher Education; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-23-002, Understanding Adult Immunization Quality 
Improvement Approaches Among Adult HCP and Health Departments; and RFA-
IP-23-003, Programmatic Interventions To Increase Uptake of Influenza 
and COVID-19 Vaccination Among Students Attending Institutions of 
Higher Education; March 29-30, 2023, 10 a.m.-5 p.m. EDT, 
Teleconference, Centers for Disease Control and Prevention, Room 1080, 
8 Corporate Boulevard, Atlanta, Georgia, 30329, in the original FRN. 
The meeting was published in the Federal Register on December 23, 2022, 
Volume 87, Number 246, pages/s/78968-78969.
    The meeting is being amended to remove the second day of the 
meeting and should read as follows:
    Date: March 29, 2023.
    Time: 10 a.m.-5 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    The meeting is closed to the public.

For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027; Telephone: (404) 718-8833; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-01800 Filed 1-27-23; 8:45 am]
BILLING CODE 4163-18-P